The Management of Anti-thyroglobulin Antibody Elevation in the Follow-up of Patients with Differentiated Thyroid Cancer
Journal Title: Nuclear Medicine Seminars - Year 2021, Vol 7, Issue 1
Abstract
The reliability of thyroglobulin (Tg) measurements in patients with differentiated thyroid cancer (DTC) decreases in anti-thyroglobulin antibody (TgAb) positivity. Although there is no definite judgment about the prognostic significance of TgAb positivity at the time of diagnosis in patients with DTC, if the TgAb value does not decrease or tends to increase during the follow-up, it may be associated with residual or recurrent disease. The management of TgAb elevation is important especially in DTC patients with normal Tg levels after radioactive iodine ablation.
Authors and Affiliations
Alev Çınar, Nuri Arslan
Keywords
Related Articles
- EP ID EP693439
- DOI 10.4274/nts.galenos.2021.0005
- Views 69
- Downloads 0
Renal Cortical Scintigraphy Procedure Guideline
This guideline is the updated version of TNTD renal cortical scintigraphy guideline published in 2001. It includes the current recommended patient doses and patient dosimetry according to international guidelines.
Oncologic Approaches for Bone Metastasis Related Pain
Bone is the third most common metastatic site after lungs and liver in advanced stages of cancer. Bone pain may be caused by local compression and/or invasion of the tumor or a pathological fracture due to bone metastasi...
Good Radiopharmacy Practices In Magistral (or Inhouse or Smallscale) Produced Radiopharmaceuticals
Radiopharmaceuticals differ from normal medicines in that they have a short half-life. Due to the rapid decay, they must be prepared shortly before their clinical use and comprehensive quality control of the final produc...
Guideline for PET/CT Imaging of Neuroendocrine Neoplasms with 68Ga-DOTA-conjugated Somatostatin Receptor Targeting Peptides
Neuroendocrine tumors (NETs) are one of the rare cancers that have been increasing in recent years. The importance of Ga-68 DOTA-Conjugated Peptides Receptor imaging has been reported in many retrospective and prospectiv...
The Use of F-18-FDG PET/CT in Renal and Bladder Tumors
Clinical imaging has been the cornerstone to guide patient management and therapy strategies for oncology patients. In the last decades, the use of fluorodeoxyglucose positron emission tomography/computed tomography (PET...